Combination Products: US FDA Extends Safety-Reporting Deadline
After major post-market safety reporting rule in 2016, guidance adds context for companies developing combination products. FDA also extends compliance deadlines in many cases until 2019.
You may also be interested in...
US FDA’s final rule includes several clarifications about its scope and definitions, and includes some additional reporting requirements.
Final reg includes several clarifications about its scope and definitions, and also includes some additional reporting requirements.
The mixture in some faulty Abbott PCR tests could cause COVID-19 positive samples to flow into neighboring negative samples, resulting in false-positive results.